Showing posts with label Samsung Electronics. Show all posts
Showing posts with label Samsung Electronics. Show all posts

Wednesday, October 19, 2016

Samsung Electronics to compensate component suppliers for Galaxy Note 7 parts

Samsung Electronics to compensate component suppliers for Galaxy Note 7 parts

Samsung Electronics Co Ltd said on Tuesday it will compensate component suppliers for the discontinued Galaxy Note 7 smartphones and consider giving them orders for other models to cushion the blow.
The world’s top smartphone maker said it would fully pay for unused Note 7 parts that have already been manufactured, compensate suppliers for unfinished components and pay for materials bought to make Note 7 parts.
“Samsung will determine the inventory levels for the partner companies and carry out compensation quickly,” the company said in a statement, without elaborating on how much it expected to pay.
The decision comes after some South Korean government and central bank officials voiced concerns about the potential impact of the Note 7 crisis on the domestic economy. A deputy finance minister said the fallout could hurt the economy during the third and fourth quarters of the year.
Though most of Samsung’s smartphones are manufactured overseas, the company is a key customer for many South Korean parts makers including Samsung Electronics affiliate Samsung Electro-Mechanics Co Ltd.
Samsung last week permanently ended sales of the fire-prone Galaxy Note 7 smartphone less than two months after launch, a decision the company expects will cost $5.5 billion in operating profit from the third quarter of 2016 to the first quarter of 2017.
Reuters

Saturday, October 15, 2016

Samsung Mobile Chief gets employee support despite Note 7 fiasco

Samsung Mobile Chief gets employee support despite Note 7 fiasco

By 
The Galaxy Note 7 has been a major blow for Samsung. After repeated replacements of the flagship device, the company had no choice but to kill it. Samsung Electronics Mobile Chief, Koh Dong-jin is in bit of a soup and probably the first time since he started heading the division in 2014.
Today he pledged that he would at any cost find the exact cause of the issue to restore consumer trust so that they can use Samsung products in the future without any safety issues. He also admitted that he was frustrated over the past weeks due to the Note 7 crisis. He apologized and expressed his gratitude to the Samsung team for their support in the tough times.
Some Samsung employees have said to put up a series of posts on Samsung’s online message board to support the head, the company and to boost the morale of other employees.
Koh took over the position after his predecessor JK Shin stepped down. He is said to have played a vital role in when it comes to innovations like the S-Pen as well as Samsung Pay. There are also rumours that Samsung Group could remove him from his position following the fiasco. Thankfully Samsung Electronics’ shares rose 3 percent to 1,581,000 won in early morning trading on 13 October.

Thursday, October 6, 2016

Activist investor Elliott’s attempt to transform Samsung may push founding family to embrace change

Activist investor Elliott’s attempt to transform Samsung may push founding family to embrace change

Image Credit: REUTERS
Samsung Electronics Co shares jumped to a record high on Thursday after activist investor Elliott Management submitted unsolicited proposals for a radical corporate makeover at the world’s biggest smartphone maker. An attempt by the U.S. hedge fund to wring change at South Korea’s biggest conglomerate last year failed in acrimony. But investors and analysts said Elliott’s latest move could open the way for the founding Lee family to embrace change, cementing its grip as it negotiates succession from its ailing patriarch to the next generation and a hefty inheritance tax bill.
The approach on Wednesday by Elliott, which owns 0.62 percent of Samsung Electronics, came as the tech giant faced fresh claims of problems with its flagship Note 7 smartphone, with a report that a handset began smoking inside a U.S. plane on Wednesday. Last month’s global recall of 2.5 million devices is set to show up in modest earnings growth guidance the firm is expected to report on Friday.
Samsung said it will “carefully review” Elliott proposals for restructuring, splitting the firm into a

Wednesday, October 5, 2016

Strong chip sales in Q3 will help Samsung ease financial impact after Note 7 fiasco

Strong chip sales in Q3 will help Samsung ease financial impact after Note 7 fiasco

Image: Reuters
Scarred by the global recall of its flagship smartphone, Samsung Electronics Co is set to report on Friday it still expects a small rise in third-quarter profit, analysts say, with healthy sales of memory chips and displays easing the pain. Lost sales and expenses tied to the recall of at least 2.5 million Galaxy Note 7 handsets to fix battery problems could cost the firm nearly $5 billion this year, some analysts have said. That could sap momentum from a nascent recovery in Samsung’s mobile business, an underperformer in recent years.
But a pickup in the memory chip market, led by demand from rival smartphone maker Apple Inc, will buttress earnings, company watchers say. A Thomson Reuters SmartEstimate, derived from a survey of 20 analysts, tips overall July-September operating profit to have edged up 0.7 percent from a year earlier to 7.4 trillion won ($6.65 billion).
“So long as the operating profit number comes in at a low 7 trillion won level, the market will look at it and think some of noise surrounding the Note 7 recall issue has cleared,” said HDC Asset Management fund manager Park Jung-hoon. Analysts have lowered their expectations for Samsung’s mobile division since the Sept. 2 recall made global headlines. Some have cut their mobile division profit forecast by 1 trillion won or more to reflect the lost sales chipand costs of recalling a smartphone that had won rave reviews and made a strong sales start since its launch in Aug. 19.
Korea Investment analyst Jay Yoo forecast Samsung’s third-quarter mobile division operating profit at 2.6 trillion won, up from 2.4 trillion won a year earlier but down from 4.3 trillion won in April-June. But analysts say Samsung’s chips division – the firm is the world’s biggest memory chip maker – will soothe the Note 7 woes as other smartphone makers filled chip order books and drove prices higher ahead of the peak year-end shopping season. Analysts estimate the division could report quarterly operating profit of 3 trillion won or more – its highest in four quarters.
Analysts said the semiconductors uptrend was more pronounced for NAND memory chips – used for long-term data storage – as demand started to outpace supply during the quarter due to orders from Apple and Chinese smartphone makers. Demand for solid-state drive storage chips for mobile devices also grew. Samsung stands to benefit from the upswing – especially in the NAND market, where it dominates rivals such as Japan’s Toshiba Corp and U.S. firm Micron Technology Inc in the market for high-end 3D products such as enterprise servers and storage.
Samsung’s display business earnings also likely picked up some of the slack from the mobile division thanks to increasing adoption of its organic light-emitting diode displays (OLED) by rising Chinese smartphone makers such as OPPO and VIVO, analysts said. “While the Galaxy Note 7 recall is a painful blow, the third quarter will show that components including DRAM, NAND and displays did better than expected,” Dongbu Securities said in a report, tipping operating profit for the chips division to be at 3 trillion won.
Reuters

Tuesday, October 4, 2016

Biotech drugs maker Samsung BioLogics IPO expected to raise $2 billion in South Korea

Biotech drugs maker Samsung BioLogics IPO expected to raise $2 billion in South Korea

Image Credit: REUTERS
Samsung BioLogics Co Ltd, a contract manufacturer of biotech drugs for global pharmaceutical firms, said on Tuesday its initial public offering is expected to raise as much as $2 billion in what is set to be South Korea’s third-largest IPO. The listing is aimed at helping fund an ambitious expansion in production capacity to make it the world’s largest contract manufacturer.
The offering of about 17 percent of the company is expected to consist of a new share issue of 11 million shares and the sale of 5.5 million existing shares by Samsung Electronics Co Ltd. With an indicative pricing range of 113,000 won-136,000 won per share, the offering is expected to raise 2.25 trillion won ($2 billion). BioLogics said 780 billion won of the proceeds will be used for factory investment, while another 400 billion won will be invested in biosimilar drug developer unit Samsung Bioepis.
Samsung Electronics is the second-largest shareholder in BioLogics after Samsung C&T Corp, the de facto holding company for the Samsung Group. C&T and related shareholders will own 74.93 percent of the company after the listing. BioLogics expects to announce final pricing for the IPO on Oct. 28. This comes after Samsung electronics resumed the sale of ‘safe’ Samsung Galaxy Note 7 smartphones.
With inputs from Reuters

Related Posts Plugin for WordPress, Blogger...